Showing results (291-300 of 379) with videos related to
Sort By:
Pageof 38
The Journal of Clinical Investigation|December 1, 1984
Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjectsJ Shepherd, C J Packard, J M Stewart, et al.Atherosclerosis|December 17, 2009
Lipoprotein-associated phospholipase A(2), inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Muriel J Caslake, Chris J Packard, Michele Robertson, et al.Diabetologia|September 29, 2023
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapyMarja-Riitta Taskinen, Niina Matikainen, Elias Björnson, et al.Circulation|July 16, 2003
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention StudyNaveed Sattar, Allan Gaw, Olga Scherbakova, et al.BMC Public Health|April 23, 2008
Psychological, social and biological determinants of ill health (pSoBid): study protocol of a population-based studyYoga N Velupillai, Chris J Packard, G David Batty, et al.European Heart Journal|January 22, 2026
Risk-weighted apoB: a novel summary metric outperforming traditional lipid biomarkers in predicting coronary heart diseaseMichaela B Rehman, Elias Björnson, Martin Adiels, et al.Diabetes, Obesity & Metabolism|January 27, 2021
Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetesMarja-Riitta Taskinen, Elias Björnson, Niina Matikainen, et al.The British Journal of Nutrition|May 7, 2018
Association of oily fish intake, sex, age, BMI and APOE genotype with plasma long-chain n-3 fatty acid compositionHelena L Fisk, Michael Irvine, Elizabeth A Miles, et al.Journal of Medical Genetics|July 25, 1998
Identification of a common low density lipoprotein receptor mutation (C163Y) in the west of ScotlandW K Lee, L Haddad, M J Macleod, et al.JAMA|November 12, 2009
Major lipids, apolipoproteins, and risk of vascular disease, Emanuele Di Angelantonio, Nadeem Sarwar, et al.Pageof 38